Healthy Clinical Trial
Official title:
Gait Pattern Analysis and Feasibility of Gait Training With a Newly Developed Walking Assist Robot in Stroke Patients and Elderly Adults
The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to gait rehabilitation in elderly adults and stroke patients.
Randomized, two treatment groups
Number of Subjects : 54 subjects (n=27 per group)
Group 1 : gait rehabilitation with hip assist robot / 10 sessions (5sessions - treadmill gait
training / 5sessions - overground gait training), 30min per session
Group 2 : gait rehabilitation without hip assist robot / 10 sessions (5sessions - treadmill
gait training / 5sessions - overground gait training), 30min per session
Primary objective is to demonstrate the effects of hip assist robot on spatio-temporal
parameters measured by motion capture system (Motion Analysis Corporation, Santa Rosa, CA,
USA), muscle activation patterns measured by surface electromyography (sEMG) (Noraxon Inc.,
Scottsdale, AZ, USA), metabolic energy cost parameters measured by portable cardiopulmonary
metabolic system (Cosmed K4B2, Rome, Italy) and foot pressure distribution measured by F-Scan
Mobile system (Tekscan Inc., South Boston, MA, USA).
Secondary objective is to demonstrate the effects of hip assist robot on motor function
improvement evaluated by Berg Balance Scale (BBS), Tinetti performance oriented mobility
assessment (POMA), Korean version Modified Bathel index (K-MBI), Modified Rankin Scale (MRS),
Functional Ambulation Classification (FAC), Fugl-Meyer assessment for lower extremity (FMA),
Korean version Fall Efficacy Scale (K-FES), Manual Muscle Test (MMT) and Range of Motion
(ROM).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |